Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pegram

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Oncogene|August 28, 1997
Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomasD MacGrogan, M Pegram, D Slamon, et al.
Current Opinion in Structural Biology|August 23, 2021
Dynamic equilibria in protein kinasesLaurel M Pegram, Jake W Anderson, Natalie G Ahn
Biochemistry|April 16, 1998
Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1R Landgraf, M Pegram, D J Slamon, et al.
Lancet (London, England)|March 2, 1985
Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemiaL C Chan, S M Pegram, M F Greaves
Journal of Nursing Management|May 13, 2014
Strengthening the role of the ward manager: a review of the literatureAnne M Pegram, Michelle Grainger, Janice Sigsworth, et al.
Techniques in Coloproctology|January 19, 2005
Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancerC Emmanouilides, M Pegram, R Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Quantifying why urea is a protein denaturant, whereas glycine betaine is a protein stabilizerEmily J Guinn, Laurel M Pegram, Michael W Capp, et al.
British Journal of Cancer|February 18, 2010
Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancerB Royer, W Yin, M Pegram, et al.
Leukemia Research|January 1, 1985
The human leucocyte-common (LC) molecule: dissection of leukaemias using monoclonal antibodies directed against framework and restricted antigenic determinantsM A Ritter, C A Sauvage, S M Pegram, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Why Hofmeister effects of many salts favor protein folding but not DNA helix formationLaurel M Pegram, Timothy Wendorff, Robert Erdmann, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Oncogene|August 28, 1997
Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomasD MacGrogan, M Pegram, D Slamon, et al.
Current Opinion in Structural Biology|August 23, 2021
Dynamic equilibria in protein kinasesLaurel M Pegram, Jake W Anderson, Natalie G Ahn
Biochemistry|April 16, 1998
Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1R Landgraf, M Pegram, D J Slamon, et al.
Lancet (London, England)|March 2, 1985
Contribution of immunophenotype to the classification and differential diagnosis of acute leukaemiaL C Chan, S M Pegram, M F Greaves
Journal of Nursing Management|May 13, 2014
Strengthening the role of the ward manager: a review of the literatureAnne M Pegram, Michelle Grainger, Janice Sigsworth, et al.
Techniques in Coloproctology|January 19, 2005
Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancerC Emmanouilides, M Pegram, R Robinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2011
Quantifying why urea is a protein denaturant, whereas glycine betaine is a protein stabilizerEmily J Guinn, Laurel M Pegram, Michael W Capp, et al.
British Journal of Cancer|February 18, 2010
Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancerB Royer, W Yin, M Pegram, et al.
Leukemia Research|January 1, 1985
The human leucocyte-common (LC) molecule: dissection of leukaemias using monoclonal antibodies directed against framework and restricted antigenic determinantsM A Ritter, C A Sauvage, S M Pegram, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Why Hofmeister effects of many salts favor protein folding but not DNA helix formationLaurel M Pegram, Timothy Wendorff, Robert Erdmann, et al.
Pageof 4